𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography

✍ Scribed by R.J Burcombe; A Makris; M Pittam; J Lowe; J Emmott; W.L Wong

Book ID
117657475
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
93 KB
Volume
38
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Evaluation of chemotherapy response in p
Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography
✍ Val J. Lowe; Frank R. Dunphy; Mark Varvares; Han Kim; Mark Wittry; Cherie H. Dun πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 186 KB πŸ‘ 2 views

## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m

Monitoring of early response to neoadjuv
Monitoring of early response to neoadjuvant chemotherapy in breast cancer with 1H MR spectroscopy: Comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography
✍ Mitsuhiro Tozaki; Masaaki Sakamoto; Yu Oyama; Toshihiro O'uchi; Naoko Kawano; Ta πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 310 KB

## Abstract ## Purpose To assess the efficacy of ^1^H MR spectroscopy (MRS) to evaluate early responses to neoadjuvant chemotherapy in breast cancer patients, as compared to that of the standardized uptake value (SUV) in ^18^F‐fluorodeoxyglucose (FDG) positron emission tomography (PET). ## Materi